Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma

Loss of LKB1 activity is prevalent in KRAS mutant lung adenocarcinoma and promotes aggressive and treatment-resistant tumors. Previous studies have shown that LKB1 is a negative regulator of the focal adhesion kinase (FAK), but in vivo studies testing the efficacy of FAK inhibition in LKB1 mutant ca...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JCI Insight
Autors principals: Gilbert-Ross, Melissa, Konen, Jessica, Koo, Junghui, Shupe, John, Robinson, Brian S., Wiles, Walter Guy, Huang, Chunzi, Martin, W. David, Behera, Madhusmita, Smith, Geoffrey H., Hill, Charles E., Rossi, Michael R., Sica, Gabriel L., Rupji, Manali, Chen, Zhengjia, Kowalski, Jeanne, Kasinski, Andrea L., Ramalingam, Suresh S., Fu, Haian, Khuri, Fadlo R., Zhou, Wei, Marcus, Adam I.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5333956/
https://ncbi.nlm.nih.gov/pubmed/28289710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.90487
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars